Guimei Li

845 total citations
30 papers, 583 citations indexed

About

Guimei Li is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Guimei Li has authored 30 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Epidemiology. Recurrent topics in Guimei Li's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Influenza Virus Research Studies (5 papers) and Lipid metabolism and disorders (4 papers). Guimei Li is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Influenza Virus Research Studies (5 papers) and Lipid metabolism and disorders (4 papers). Guimei Li collaborates with scholars based in China, United States and Japan. Guimei Li's co-authors include Kazuyoshi Ikuta, Shu‐Ming Li, Yonggang Li, Masanobu Yamate, Rafi Ahmed, Adolfo Garcı́a-Sastre, Patrick C. Wilson, Shuang Liang, Megan McCausland and Jens Wrammert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Guimei Li

28 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guimei Li China 11 276 174 171 135 72 30 583
Lopa Adhikary United States 6 324 1.2× 81 0.5× 145 0.8× 172 1.3× 46 0.6× 6 483
Qingming Dong China 14 226 0.8× 230 1.3× 134 0.8× 228 1.7× 67 0.9× 35 764
Shaogeng Zhang China 16 252 0.9× 518 3.0× 140 0.8× 494 3.7× 28 0.4× 48 1.2k
Laura Riva United States 10 241 0.9× 204 1.2× 202 1.2× 235 1.7× 11 0.2× 29 677
Daryl Humes United States 13 198 0.7× 168 1.0× 135 0.8× 119 0.9× 10 0.1× 23 632
Sayuri Uehara Japan 7 235 0.9× 236 1.4× 80 0.5× 148 1.1× 21 0.3× 7 557
Weiwen Liang China 13 90 0.3× 97 0.6× 87 0.5× 144 1.1× 36 0.5× 23 413
Julia D. Rempel Canada 16 201 0.7× 119 0.7× 194 1.1× 88 0.7× 23 0.3× 36 659
Xiaomei Li China 12 209 0.8× 67 0.4× 39 0.2× 136 1.0× 44 0.6× 22 428

Countries citing papers authored by Guimei Li

Since Specialization
Citations

This map shows the geographic impact of Guimei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guimei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guimei Li more than expected).

Fields of papers citing papers by Guimei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guimei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guimei Li. The network helps show where Guimei Li may publish in the future.

Co-authorship network of co-authors of Guimei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guimei Li. A scholar is included among the top collaborators of Guimei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guimei Li. Guimei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xiaochao, Jian Tang, Guimei Li, et al.. (2025). Discovery of novel combretastatin A4 derivatives as a microtubule targeting agent capable of inducing HepG-2 cell apoptosis via the mitochondria and ER stress mediated pathway. Bioorganic Chemistry. 163. 108676–108676. 1 indexed citations
2.
3.
Yang, Jianmei, et al.. (2025). Clinical and genetic analysis of ulnar-mammary syndrome caused by a novel <i>TBX3</i> mutation in a Chinese boy. Intractable & Rare Diseases Research. 14(2). 128–134.
4.
Wang, Meng, Guimei Li, Guiyang Jiang, et al.. (2024). Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance. Journal of Medicinal Chemistry. 67(8). 6218–6237. 12 indexed citations
5.
Wang, Meng, Guimei Li, Guiyang Jiang, et al.. (2023). Dual-targeting tumor cells hybrids derived from Pt(IV) species and NF-κB inhibitors enables cancer therapy through mitochondrial dysfunction and ER stress and overcomes cisplatin resistance. European Journal of Medicinal Chemistry. 266. 116095–116095. 12 indexed citations
6.
Wang, Shuping, Yiping Cheng, Wan‐Yi Zhao, et al.. (2022). Identification and Characterization of Two Novel Compounds: Heterozygous Variants of Lipoprotein Lipase in Two Pedigrees With Type I Hyperlipoproteinemia. Frontiers in Endocrinology. 13. 874608–874608. 4 indexed citations
7.
Li, Guimei, et al.. (2022). Effects of growth hormone on lipid metabolism and sexual development in pubertal obese male rats. Open Life Sciences. 17(1). 1531–1540. 2 indexed citations
8.
Li, Yan, et al.. (2019). Differential analysis of nutrient intake, insulin resistance and lipid profiles between healthy and premature thelarche Chinese girls. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 45(1). 166–166. 3 indexed citations
9.
Liang, Shuang, Jiang Xue, & Guimei Li. (2018). Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency. Lipids in Health and Disease. 17(1). 66–66. 14 indexed citations
10.
11.
Mick, Gail J., et al.. (2016). Cortisol promotes endoplasmic glucose production via pyridine nucleotide redox. Journal of Endocrinology. 229(1). 25–36. 2 indexed citations
12.
Huang, Jinhua, Zhijie Li, Guimei Li, & Zhao‐Ying Liu. (2015). Validation of the Andon KD-5965 upper-arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010. Blood Pressure Monitoring. 20(5). 283–285. 1 indexed citations
13.
Chen, Xiaoyun, Qing Dong, & Guimei Li. (2015). Effect of combined application insulin and insulin detemir on continous glucose monitor in children with type 1 diabetes mellitus.. PubMed. 8(3). 4287–91. 1 indexed citations
14.
Zhang, Chuanmei, Hu Shan, Jianlin Wang, et al.. (2015). Avian influenza virus H9N2 infections in farmed minks. Virology Journal. 12(1). 180–180. 25 indexed citations
15.
Li, Guimei, et al.. (2013). Characteristics of girls with pituitary hyperplasia and sexual precocity secondary to primary hypothyroidism. Acta Paediatrica. 103(1). e43–8. 7 indexed citations
16.
Chiu, Christopher, Jens Wrammert, Guimei Li, et al.. (2013). Cross‐reactive humoral responses to influenza and their implications for a universal vaccine. Annals of the New York Academy of Sciences. 1283(1). 13–21. 27 indexed citations
17.
Li, Yonggang, Pranee Thawatsupha, Malinee Chittaganpitch, et al.. (2008). Higher in vitro susceptibility of human T cells to H5N1 than H1N1 influenza viruses. Biochemical and Biophysical Research Communications. 371(3). 484–489. 6 indexed citations
18.
Iwabu, Yukie, Yonggang Li, Guimei Li, et al.. (2007). Aberrant life cycle of human immunodeficiency virus type 1 CRF15_01B-like clinical isolates from Thailand in human CD4+ T-cell lines. Microbes and Infection. 9(4). 449–459. 1 indexed citations
19.
Li, Guimei, Yonggang Li, Masanobu Yamate, Shu‐Ming Li, & Kazuyoshi Ikuta. (2006). Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes and Infection. 9(1). 96–102. 148 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lopa Adhikary Breakdown of academic impact, for papers by Qingming Dong Breakdown of academic impact, for papers by Shaogeng Zhang Breakdown of academic impact, for papers by Laura Riva Breakdown of academic impact, for papers by Daryl Humes Breakdown of academic impact, for papers by Sayuri Uehara Breakdown of academic impact, for papers by Weiwen Liang Breakdown of academic impact, for papers by Julia D. Rempel Breakdown of academic impact, for papers by Xiaomei Li
Rankless by CCL
2026